Stock Analiz

Medirom Healthcare Technologies Inc. MRM

Other Consumer Services · IPO 2020 · data as of November 13, 2026

$0.28Market cap $2M
Open the interactive analysis →

Medirom Healthcare Technologies Inc. (MRM) is a consumer discretionary company listed in the US with a market value of about $2M. In fiscal year 2024 it had revenue of $53M and net income of $947837, a net margin of 1.8%.

Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is value (3/5); the weakest is future growth (0/5).

Key numbers: a P/E of 2.3, 5-year revenue growth of 8% a year, a 5-year average ROIC of -8%.

About Medirom Healthcare Technologies

Medirom Healthcare Technologies is listed in the US and classified in other consumer services, IPO year 2020. Revenue went from $36M in 2019 to $53M in 2024, growth of about 8.0% a year. It was profitable in 4 of the last 6 years in our data.

Score: 1.0 / 5

Value3/5
Future growth0/5
Track record2/5
Financial health0/5
Shareholder returns0/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • PEG below 1.5
  • 5-year EPS growth above 10% a year
  • ROE above 15%

Checks not passed

  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%
  • 5-year revenue growth above 8% a year

Valuation

P/E (TTM)2.3
Forward P/E—
P/FCF—
P/S0.0
P/B0.4
EV/EBITDA12.8
PEG0.06
Dividend yield0.00%
FCF yield-408.4%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)9.6%
Revenue growth (5 yrs, per year)8.0%
EPS growth (5 yrs, per year)37.2%
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-5.8%
ROIC (5-yr avg.)-8.4%
Profitable years (of last 10)4
Years paying a dividend—

Financials, last 6 years

Fiscal year202420232022202120202019
Revenue$53M$48M$53M$47M$32M$36M
Net income$947837$815691$1M-$9M-$5M$159696
Free cash flow-$9M-$5M-$6M-$6M-$4M$4275
EPS (diluted)$0.12$0.10$0.14$-1.09$-0.66$0.02
Net margin1.8%1.7%2.1%-18.3%-16.1%0.4%
ROIC-0.3%-8.9%2.5%-14.4%-21.0%0.6%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

What is Medirom Healthcare Technologies’s P/E ratio?

About 2.3, based on the last twelve months of diluted earnings per share.

Does Medirom Healthcare Technologies pay a dividend?

Not currently.

Is Medirom Healthcare Technologies a good stock to buy?

We do not give buy or sell advice. Medirom Healthcare Technologies scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.